-
Founded in:
1997-12-30 -
Country:
China -
Address:
Wangtai, Jincheng City, Shanxi Province -
Tax NO.:
91140500111208832X -
Registered Funds:
148.512131 yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ofloxacin |
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial activity against most bacteria of the Enterobacteriaceae family, Pseudomonas aeruginosa, and methicillin-sensitive Staphylococcus. It has good antimicrobial effects on Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibits DNA synthesis and replication, and causes bacterial death. At present, there is an increasing trend in clinical drug resistance, and there is cross-resistance with other quinolones.
More
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial activity against most bacteria of the Enterobacteriaceae family, Pseudomonas aeruginosa, and methicillin-sensitive Staphylococcus. It has good antimicrobial effects on Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibits DNA synthesis and replication, and causes bacterial death. At present, there is an increasing trend in clinical drug resistance, and there is cross-resistance with other quinolones. |
82419-36-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ofloxacin |
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative rods, and has good antibacterial activity against the following bacteria in vitro: 1. Most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It also has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae, and Moraxella. 2. It has antibacterial activity against most strains of Pseudomonas, such as Pseudomonas aeruginosa. 3. It has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial effects against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. 4. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. The drug resistance of this product is currently increasing, and there is cross-resistance with other quinolones.
More
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative rods, and has good antibacterial activity against the following bacteria in vitro: 1. Most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It also has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae, and Moraxella. 2. It has antibacterial activity against most strains of Pseudomonas, such as Pseudomonas aeruginosa. 3. It has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus, and Enterococcus faecalis. It has good antimicrobial effects against Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. 4. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. The drug resistance of this product is currently increasing, and there is cross-resistance with other quinolones. |
82419-36-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Glycyrrhizic acid |
Anti-inflammatory effects: (1) Anti-allergic effects: It can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects; (2) Inhibitory effect on arachidonic acid metabolic enzymes: It can directly bind to phospholipase A2, the starting enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.
More
Anti-inflammatory effects: (1) Anti-allergic effects: It can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects; (2) Inhibitory effect on arachidonic acid metabolic enzymes: It can directly bind to phospholipase A2, the starting enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators. |
1405-86-3 | 1 | |
| L-Cysteine monohydrochloride |
1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.
More
1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators. |
52-89-1 | 10 | |
| Glycine |
1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators.
More
1 Anti-inflammatory effect (1) Anti-allergic effect: Glycyrrhizic acid glycoside can inhibit local allergic reactions in rabbits (Arthus Phenomenon) and inhibit Schwartsman phenomenon (Shwartsman Phenomenon) and other anti-allergic effects. For corticosteroids, it can enhance the hormone's inhibitory effect on stress response and antagonize the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibition of arachidonic acid metabolic enzymes Glycyrrhizic acid glycoside can directly bind to phospholipase A2, the initiator enzyme of the arachidonic acid metabolic pathway, and act on arachidonic acid to produce inflammatory mediators. |
56-40-6 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lansoprazole |
Extract from the above information
More
Extract from the above information |
103577-45-3 | 88 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Captopril |
It mainly inhibits the activity of angiotensin converting enzyme, lowers the level of angiotensin II, reduces the secretion of aldosterone, dilates arteries and veins, achieves a antihypertensive effect and reduces the preload and afterload of the heart to improve cardiac function.
More
It mainly inhibits the activity of angiotensin converting enzyme, lowers the level of angiotensin II, reduces the secretion of aldosterone, dilates arteries and veins, achieves a antihypertensive effect and reduces the preload and afterload of the heart to improve cardiac function. |
62571-86-2 | 28 | |
| Hydrochlorothiazide |
It mainly increases the excretion of sodium chloride by the kidneys, thereby playing a diuretic role, reducing blood volume and exerting a blood pressure lowering effect.
More
It mainly increases the excretion of sodium chloride by the kidneys, thereby playing a diuretic role, reducing blood volume and exerting a blood pressure lowering effect. |
58-93-5 | 56 |